BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 18572453)

  • 1. Genetics of warfarin response.
    Mannucci PM; Spreafico M; Peyvandi F
    N Engl J Med; 2008 Jun; 358(25):2743; author reply 2743-4. PubMed ID: 18572453
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetics of warfarin response.
    Neville KA; Wicklund BM; Kearns GL
    N Engl J Med; 2008 Jun; 358(25):2742. PubMed ID: 18572452
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetics of warfarin response.
    Kulkarni UP; Karnad DR; Gogtay NJ
    N Engl J Med; 2008 Jun; 358(25):2742-3; author reply 2743-4. PubMed ID: 18572454
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic testing for warfarin dosing? Not yet ready for prime time.
    Bussey HI; Wittkowsky AK; Hylek EM; Walker MB
    Pharmacotherapy; 2008 Feb; 28(2):141-3. PubMed ID: 18225960
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacogenomics--ready for prime time?
    Shurin SB; Nabel EG
    N Engl J Med; 2008 Mar; 358(10):1061-3. PubMed ID: 18322288
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic help for a blood-thinner balancing act? There's little evidence yet that a genetic test improves the safety of warfarin.
    Harv Heart Lett; 2007 Dec; 18(4):1-2. PubMed ID: 18219801
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple gene polymorphisms and warfarin sensitivity.
    Shikata E; Ieiri I; Ishiguro S; Takane H; Ohgi S; Otsubo K
    Eur J Clin Pharmacol; 2006 Oct; 62(10):881-3. PubMed ID: 16821005
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic analysis to prevent warfarin complications.
    Lippi G; Salvagno GL; Guidi GC
    CMAJ; 2007 Aug; 177(4):377. PubMed ID: 17698833
    [No Abstract]   [Full Text] [Related]  

  • 9. Application of a pharmacogenetic-based warfarin dosing algorithm derived from British patients to predict dose in Swedish patients.
    Hatch E; Wynne H; Avery P; Wadelius M; Kamali F
    J Thromb Haemost; 2008 Jun; 6(6):1038-40. PubMed ID: 18419746
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacogenetic-based dosing of warfarin.
    Med Lett Drugs Ther; 2008 May; 50(1286):39-40. PubMed ID: 18487958
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic resistance to warfarin therapy masked by amiodarone in a 2-year-old girl with mitral valve replacement.
    Moreau C; Bajolle F; Siguret V; Loriot MA; Bonnet D
    J Thromb Haemost; 2013 Mar; 11(3):555-72. PubMed ID: 23241284
    [No Abstract]   [Full Text] [Related]  

  • 12. Refining the use of warfarin through genetic testing.
    Lee SC
    Int Angiol; 2008 Aug; 27(4):271-3. PubMed ID: 18677287
    [No Abstract]   [Full Text] [Related]  

  • 13. Genotypes of vitamin K epoxide reductase, gamma-glutamyl carboxylase, and cytochrome P450 2C9 as determinants of daily warfarin dose in Japanese patients.
    Kimura R; Miyashita K; Kokubo Y; Akaiwa Y; Otsubo R; Nagatsuka K; Otsuki T; Okayama A; Minematsu K; Naritomi H; Honda S; Tomoike H; Miyata T
    Thromb Res; 2007; 120(2):181-6. PubMed ID: 17049586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appraisal of current vitamin K dosing algorithms for the reversal of over-anticoagulation with warfarin: the need for a more tailored dosing regimen.
    Sconce EA; Kamali F
    Eur J Haematol; 2006 Dec; 77(6):457-62. PubMed ID: 17042764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Warfarin dose requirement for patients with both VKORC1 3673A/A and CYP2C9*3/*3 genotypes.
    Fukuda T; Tanabe T; Ohno M; Tougou K; Fujio Y; Azuma J; Yamamoto I; Takeda A
    Clin Pharmacol Ther; 2006 Nov; 80(5):553-4. PubMed ID: 17112813
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic determinants of dose and clinical outcomes in patients receiving oral anticoagulants.
    Schwarz UI; Stein CM
    Clin Pharmacol Ther; 2006 Jul; 80(1):7-12. PubMed ID: 16815312
    [No Abstract]   [Full Text] [Related]  

  • 17. Warfarin resistance.
    Sinxadi P; Blockman M
    Cardiovasc J Afr; 2008; 19(4):215-7. PubMed ID: 18776969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VKORC1 Asp36Tyr warfarin resistance marker is common in Ethiopian individuals.
    Aklillu E; Leong C; Loebstein R; Halkin H; Gak E
    Blood; 2008 Apr; 111(7):3903-4. PubMed ID: 18362220
    [No Abstract]   [Full Text] [Related]  

  • 19. Warfarin monitoring woes: a glimmer of hope with pharmacogenomics.
    Beier MT
    J Am Med Dir Assoc; 2008 Mar; 9(3):199-200. PubMed ID: 18294604
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacogenetics of warfarin: current status and future challenges.
    Wadelius M; Pirmohamed M
    Pharmacogenomics J; 2007 Apr; 7(2):99-111. PubMed ID: 16983400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.